| Hans-Günter Meyer-Thompson | Substitutionsmittel Verschiedenes
USA. Lofexidine: FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
USA. Lofexidine: FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority. (FDA, USA, 16.05.2018)
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm